Gene · 554
Papers2,697
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,697
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Vasopressin Receptor Antagonist Tolvaptan Counteracts Tumor Growth in a Murine Xenograft Model of Small Cell Lung Cancer. | Int J Mol Sci | 2024 | 39125971 | PubTator, text mining | PubMed |
| A Synthetic Route to Tetrahydro-1H-azepino[4,3,2-cd]indoles via Ring-Opening Cyclization of Activated Azetidines with 4-Bromoindole: Toward a Vasopressin V2 Receptor Antagonist. | J Org Chem | 2024 | 39102588 | PubTator, text mining | PubMed |
| A novel AVPR2 gene mutation in a Chinese pedigree with nephrogenic diabetes insipidus. | Postgrad Med | 2024 | 39041787 | PubTator, text mining | PubMed |
| Functional consequences of spatial, temporal and ligand bias of G protein-coupled receptors. | Nat Rev Nephrol | 2024 | 39039165 | PubTator, text mining | PubMed |
| Bayesian mapping of protein kinases to vasopressin-regulated phosphorylation sites in renal collecting duct. | Am J Physiol Renal Physiol | 2024 | 39024358 | PubTator, text mining | PubMed |
| First Immunohistochemical Demonstration of the Expression of a Type-2 Vomeronasal Receptor, V2R2, in Wild Canids. | Int J Mol Sci | 2024 | 39000398 | PubTator, text mining | PubMed |
| Role of the V2R-βarrestin-Gβγ complex in promoting G protein translocation to endosomes. | Commun Biol | 2024 | 38972875 | PubTator, text mining | PubMed |
| Structural basis of tolvaptan binding to the vasopressin V2 receptor. | Acta Pharmacol Sin | 2024 | 38902502 | PubTator, text mining | PubMed |
| In search of innovative potential : The challenge of measuring disruptiveness of research using bibliometric data. | EMBO Rep | 2024 | 38866981 | PubTator, text mining | PubMed |
| Does the primary cilium elongation play a role in urine concentration? | Kidney Res Clin Pract | 2024 | 38863383 | PubTator, text mining | PubMed |
| A Rare Case of Congenital Nephrogenic Diabetes Insipidus Associated with Aquaporin 2 Gene Mutation and Subsequent Acute Lymphoblastic Leukemia: Impact of Steroids on Kidney Function. | Am J Case Rep | 2024 | 38769718 | PubTator, text mining | PubMed |
| Therapeutic potentials of nonpeptidic V2R agonists for partial cNDI-causing V2R mutants. | PLoS One | 2024 | 38748623 | PubTator, text mining | PubMed |
| Clinical efficacy of tolvaptan in acute decompensated heart failure patients with severe aortic stenosis and atrial fibrillation: a sub-analysis from the LOHAS registry. | Heart Vessels | 2024 | 38710808 | PubTator, text mining | PubMed |
| Arginine vasopressin deficiency: diagnosis, management and the relevance of oxytocin deficiency. | Nat Rev Endocrinol | 2024 | 38693275 | PubTator, text mining | PubMed |
| A cAMP-biosensor-based assay for measuring plasma arginine-vasopressin levels. | Sci Rep | 2024 | 38658606 | PubTator, text mining | PubMed |
| Genetic analysis of nephrogenic diabetes insipidus patients: A study on the Iranian population. | Mol Genet Genomic Med | 2024 | 38622833 | PubTator, text mining | PubMed |
Retracted: A Novel Missense Mutation of Arginine Vasopressin Receptor 2 in a Chinese Family with Congenital Nephrogenic Diabetes Insipidus: X-Chromosome Inactivation in Female CNDI Patients with Heterozygote 814A>G Mutation. | Biomed Res Int | 2024 | 38550046 | PubTator, text mining | PubMed |
| Report from the 29th Meeting on Toxinology, "Toxins: From the Wild to the Lab", Organized by the French Society of Toxinology on 30 November-1 December 2023. | Toxins (Basel) | 2024 | 38535813 | PubTator, text mining | PubMed |
| Long-Residence Time Peptide Antagonist for the Vasopressin V2 Receptor to Treat Autosomal Dominant Polycystic Kidney Disease. | J Med Chem | 2024 | 38509003 | PubTator, text mining | PubMed |
| Additional renoprotective effect of the SGLT2 inhibitor dapagliflozin in a patient with ADPKD receiving tolvaptan treatment. | CEN Case Rep | 2024 | 38494546 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/554/papers?page=8